Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
ASArunee SabchareonDWDerek WallaceCSChukiat SirivichayakulKLKriengsak LimkittikulPCPornthep Chanthavanich
Mahidol Oxford Tropical Medicine Research Unit · Mahidol University · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
814
total citations
- FWCI
- 129.02
- Percentile
- 100%
- References
- 39
Citations per year
Authors
16- ASArunee SabchareonCorresponding
Mahidol Oxford Tropical Medicine Research Unit, Mahidol University
- DWDerek Wallace
- CSChukiat Sirivichayakul
Mahidol Oxford Tropical Medicine Research Unit, Mahidol University
- KLKriengsak Limkittikul
Mahidol Oxford Tropical Medicine Research Unit, Mahidol University
- PCPornthep Chanthavanich
Mahidol University, Mahidol Oxford Tropical Medicine Research Unit
Topics & keywords
Topics
Keywords
- Medicine
- Dengue fever
- Dengue vaccine
- Placebo
- Serotype
- Vaccine efficacy
- Dengue virus
- Population
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.